Overview of Taris GemRIS, a Novel Drug Delivery System for Bladder Cancer.
Publication
, Journal Article
Grimberg, DC; Shah, A; Inman, BA
Published in: Eur Urol Focus
July 15, 2020
GemRIS, an implantable drug delivery system from Taris Biomedical that delivers continuous intravesical gemcitabine, shows potential for use in multiple bladder cancer settings. Ongoing and recently completed phase 1 trials in non-muscle-invasive as well as muscle-invasive bladder cancer are yielding promising preliminary results.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Eur Urol Focus
DOI
EISSN
2405-4569
Publication Date
July 15, 2020
Volume
6
Issue
4
Start / End Page
620 / 622
Location
Netherlands
Related Subject Headings
- Urinary Bladder Neoplasms
- Humans
- Gemcitabine
- Drug Delivery Systems
- Deoxycytidine
- Antimetabolites, Antineoplastic
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Grimberg, D. C., Shah, A., & Inman, B. A. (2020). Overview of Taris GemRIS, a Novel Drug Delivery System for Bladder Cancer. Eur Urol Focus, 6(4), 620–622. https://doi.org/10.1016/j.euf.2019.09.006
Grimberg, Dominic C., Ankeet Shah, and Brant A. Inman. “Overview of Taris GemRIS, a Novel Drug Delivery System for Bladder Cancer.” Eur Urol Focus 6, no. 4 (July 15, 2020): 620–22. https://doi.org/10.1016/j.euf.2019.09.006.
Grimberg DC, Shah A, Inman BA. Overview of Taris GemRIS, a Novel Drug Delivery System for Bladder Cancer. Eur Urol Focus. 2020 Jul 15;6(4):620–2.
Grimberg, Dominic C., et al. “Overview of Taris GemRIS, a Novel Drug Delivery System for Bladder Cancer.” Eur Urol Focus, vol. 6, no. 4, July 2020, pp. 620–22. Pubmed, doi:10.1016/j.euf.2019.09.006.
Grimberg DC, Shah A, Inman BA. Overview of Taris GemRIS, a Novel Drug Delivery System for Bladder Cancer. Eur Urol Focus. 2020 Jul 15;6(4):620–622.
Published In
Eur Urol Focus
DOI
EISSN
2405-4569
Publication Date
July 15, 2020
Volume
6
Issue
4
Start / End Page
620 / 622
Location
Netherlands
Related Subject Headings
- Urinary Bladder Neoplasms
- Humans
- Gemcitabine
- Drug Delivery Systems
- Deoxycytidine
- Antimetabolites, Antineoplastic
- 3202 Clinical sciences
- 1103 Clinical Sciences